A Scalable, Affordable PV Platform with Real Solutions for SMEs

Pharmacovigilance (PV) is critical to the safety of medicines, ensuring that adverse effects are detected, assessed, and managed to protect public health. However, most PV solutions on the market are designed for large pharmaceutical companies — meaning they are often complex, costly, and inaccessible for smaller businesses.

Developed in collaboration with Regxia, RegDocs365’s PV module offers an affordable and scalable solution tailored specifically for small to mid-sized companies, making it easier than ever to meet post-authorization safety commitments.

Why Choose the PV Module for RegDocs365?

Small companies often struggle with manual processes or patchwork solutions for managing PV, but with this module, those challenges are a thing of the past.

  • Complete End-to-End Workflow: From case intake to signal detection, this module covers the entire pharmacovigilance process, supporting your team from the moment a new event is reported through adjudication and regulatory submission.
  • Fully Compliant: Our solution meets the stringent requirements of global regulatory authorities, ensuring that your PV processes are always in line with industry standards.
  • Affordable and Scalable: Unlike the big players, which can be prohibitively expensive for smaller companies, our PV module is cost-effective and designed to grow with your business.
  • Intuitive and Easy to Use: This module has a user-friendly interface that allows for seamless case processing, from reporting adverse events to generating line listings suitable for periodic safety reports.

Key Features Include:

  • Streamlined Case Intake: Receive and categorize adverse event reports from various sources, including healthcare professionals, patients, and regulatory authorities. Easily track the report’s status and ensure timely processing.
  • Comprehensive Case Management: Process cases easily, send them for adjudication, assess for regulatory reportability, and generate reports in compliance with requirements.
  • Signal Detection & Management: Detect and analyze safety signals with confidence, helping you proactively manage risks and ensure your products’ safety.

The Fit-for-Purpose Solution

This PV Module is a perfect example of a fit-for-purpose solution. While large companies have expansive needs, smaller companies require streamlined, efficient, and cost-effective solutions. Regxia, a consulting group specializing in regulatory affairs and pharmacovigilance, saw firsthand the gap in the market for smaller businesses and partnered with Court Square Group to create a PV solution that meets this need.

The Pharmacovigilance Module for RegDocs365 empowers smaller companies with the tools they need to stay compliant and competitive in an ever-evolving regulatory landscape. Say goodbye to manual processes and cobbled-together solutions — this module offers a complete, streamlined system that fits your budget and your business needs.

Ready to simplify your pharmacovigilance operations?

Contact Us
First
Last

Dive In

Introducing the Pharmacovigilance (PV) Module for RegDocs365™. A Scalable, Affordable PV Platform with Real Solutions for SMEs

 

Questions we are often asked about Pharmacovigilance

What is pharmacovigilance software, and what does it help companies do?

Pharmacovigilance software helps life sciences companies collect, assess, track, and report information about adverse events and other product safety issues. A centralized PV system can support activities ranging from initial case intake and medical review to signal detection, regulatory assessment, and safety reporting.

Who is the RegDocs365 Pharmacovigilance Module designed for?

The RegDocs365 Pharmacovigilance Module is designed primarily for small to mid-sized pharmaceutical, biotechnology, and other life sciences companies. It provides a scalable alternative for organizations that need structured pharmacovigilance processes but may not require the complexity or cost of a large enterprise safety system.

Can the pharmacovigilance platform manage the complete adverse event workflow?

Yes. The platform supports an end-to-end pharmacovigilance workflow, including adverse event intake, case categorization, case processing, adjudication, reportability assessment, signal management, and regulatory submission. This helps teams manage safety information in one coordinated system rather than across disconnected tools.

How does the PV module improve adverse event intake and case management?

The module allows teams to receive and categorize adverse event reports from sources such as patients, healthcare professionals, and regulatory authorities. Users can track each case’s status, route cases for review or adjudication, assess regulatory reportability, and help ensure that required actions are completed on time.

Does the pharmacovigilance system support signal detection and safety risk management?

Yes. The system includes tools for detecting, reviewing, and managing potential safety signals. Bringing case information and signal management together can help pharmacovigilance teams identify emerging risks, evaluate patterns, and take appropriate action to protect patients.

Can RegDocs365 generate pharmacovigilance reports and line listings?

The PV module can generate case reports and line listings that may be used to support periodic safety reporting and other regulatory activities. Centralized reporting also makes it easier to retrieve, organize, and review safety information when preparing submissions or responding to questions.

Can pharmacovigilance software replace spreadsheets and manual safety processes?

A centralized PV platform can reduce reliance on spreadsheets, email, paper records, and other disconnected processes. It creates a more consistent workflow for tracking adverse events, reviewing cases, managing safety signals, and maintaining records, which can reduce duplication and improve visibility across the pharmacovigilance team.

How is a scalable PV platform different from a traditional enterprise safety system?

Traditional enterprise pharmacovigilance systems may include extensive functionality, infrastructure, and costs designed for large global organizations. A scalable, fit-for-purpose PV platform focuses on the essential capabilities smaller companies need today while allowing the system to grow as case volumes, products, users, and regulatory responsibilities increase.